CTLA-4 Blockade Boosts the Expansion of Tumor-Reactive CD8+ Tumor-Infiltrating Lymphocytes in Ovarian Cancer

Scientific Reports- United Kingdom

doi 10.1038/s41598-020-60738-4

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Kv1.3 Channels Mark Functionally Competent CD8 + Tumor-Infiltrating Lymphocytes in Head and Neck Cancer

Cancer Research
Cancer ResearchOncology
2016English

Tumor-Infiltrating Lymphocytes in Melanoma

Current Oncology Reports
Oncology
2012English

Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Co-Stimulation Through 4-1bb/Cd137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy

PLoS ONE
Multidisciplinary
2013English

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2017English

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

OncoImmunology
OncologyAllergyImmunology
2012English

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

CTLA-4 Blockade Synergizes Therapeutically With PARP Inhibition in BRCA1-Deficient Ovarian Cancer

Cancer immunology research
Cancer ResearchImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy